Evidence map›Paper›PMID 37958049›Full record

ArticleHealthcare (Basel, Switzerland)2023

Application of the Delphi Method for Content Validity Analysis of a Questionnaire to Determine the Risk Factors of the Chemsex.

Pablo Del Pozo-Herce, Antonio Martínez-Sabater, Elena Chover-Sierra, Vicente Gea-Caballero, Pedro José Satústegui-Dordá, Carles Saus-Ortega, Clara Isabel Tejada-Garrido, Mercedes Sánchez-Barba, Jesús Pérez, Raúl Juárez-Vela and 2 more

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pablo Del Pozo-HerceDepartment of Psychiatry, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.ORCID 0000-0002-2652-4895
Antonio Martínez-SabaterNursing Care and Education Research Group (GRIECE), GIUV2019-456, Nursing Department, Universitat de Valencia, 46010 Valencia, Spain.ORCID 0000-0002-6440-1431
Elena Chover-SierraNursing Care and Education Research Group (GRIECE), GIUV2019-456, Nursing Department, Universitat de Valencia, 46010 Valencia, Spain.ORCID 0000-0002-4141-6956
Vicente Gea-CaballeroResearch Group Community Health and Care, International University of Valencia, 46002 Valencia, Spain.ORCID 0000-0001-8607-3195
Pedro José Satústegui-DordáSAPIENF (B53_23R) Research Group, Faculty of Health Sciences, University of Zaragoza, 50018 Zaragoza, Spain.ORCID 0000-0003-0083-5940
Carles Saus-OrtegaNursing School La Fe, Adscript Centre, University of Valencia, 46026 Valencia, Spain.ORCID 0000-0002-4972-8559
Clara Isabel Tejada-GarridoResearch Group in Care, Faculty of Health Sciences, University of La Rioja, 26006 Logroño, Spain.ORCID 0000-0002-6261-349X
Mercedes Sánchez-BarbaFaculty of Medicine, University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0002-3324-5798
Jesús PérezFaculty of Medicine, University of Salamanca, 37007 Salamanca, Spain.
Raúl Juárez-VelaResearch Group in Care, Faculty of Health Sciences, University of La Rioja, 26006 Logroño, Spain.ORCID 0000-0003-3597-2048
Iván Santolalla-ArnedoResearch Group in Care, Faculty of Health Sciences, University of La Rioja, 26006 Logroño, Spain.ORCID 0000-0001-6705-7122
Enrique Baca-GarcíaDepartment of Psychiatry, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemsex is understood as "the intentional use of stimulant drugs to have sex for an extended time among gay, bisexual, and other men who have sex with men". It is a public health problem because of the increased incidence of cases and because of the consequences on the physical and mental health of those who practice it.

aimThis study aimed to analyze, with the help of the Delphi method, the content validity of a new instrument to assess the risk of behaviors associated with the chemsex phenomenon.

methodFirst, a bank of items identified from the literature was elaborated. Secondly, 50 experts with knowledge of the chemsex phenomenon at the national level were contacted. A Delphi group was formed with them to carry out two rounds of item evaluation. The linguistic evaluation (comprehension and appropriateness) was assessed using a Likert scale from 1 to 5 for each item. Items that did not reach a mean score of 4 were eliminated. Content assessment was calculated using each item's content validity index (CVI) and Aiken's V (VdA). A minimum CVI and VdA value of 0.6 was established to include the items in the questionnaire.

resultsA total of 114 items were identified in the literature. In the first round of Delphi evaluation, 36 experts evaluated the items. A total of 58 items were eliminated for obtaining a CVI or VdA of less than 0.6, leaving 56 items. In a second Delphi round, 30 experts re-evaluated the 56 selected items, where 4 items were eliminated for being similar, and 10 items were also eliminated for not being relevant to the topic even though they had values higher than 0.6, leaving the scale finally composed of 52 items.

conclusionA questionnaire has been designed to assess the risk of behaviors associated with the chemsex phenomenon. The items that make up the questionnaire have shown adequate content and linguistic validity. The Delphi method proved to be a helpful technique for the proposed objective.

Indexed as

chemsexcontent validityDelphi methodDelphi techniqueexpert consensusexperts judgmentinstrument developmentinstrument validationpsychometricsvalidity

Identifiers

PMID37958049
PMCPMC10649857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.